Sirolimus News and Research

RSS
Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Afinitor tablets decrease size of SEGA associated with tuberous sclerosis

Afinitor tablets decrease size of SEGA associated with tuberous sclerosis

Xenogenics acquires Ideal BioStent assets

Xenogenics acquires Ideal BioStent assets

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

OrbusNeich completes enrollment in randomized clinical study of Genous Bio-engineered R stent in China

OrbusNeich completes enrollment in randomized clinical study of Genous Bio-engineered R stent in China

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

OrbusNeich completes enrollment in Combo Bio-engineered Sirolimus Eluting Stent clinical trial

OrbusNeich completes enrollment in Combo Bio-engineered Sirolimus Eluting Stent clinical trial

Use of CYPHER stent in diabetic patients can result in significant cost savings

Use of CYPHER stent in diabetic patients can result in significant cost savings

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Biodegradable polymers represent future of stent design

Biodegradable polymers represent future of stent design

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Data from ESC confirms reduction in adverse events with CYPHER Stent

Data from ESC confirms reduction in adverse events with CYPHER Stent

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML